Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

En+ Group wants to build three large HPPs in the next 10-15 years

7/23/24 ENPG

TGC-1 increased energy generation by 9%

7/23/24 TGKA

Chain of dumplings and meat producer decided to pre-IPO

7/23/24 OTCI

Moscow Exchange has changed its bank for yuan settlements

7/23/24 MOEX

TCS Holding became the owner of the broker Investment Solutions

7/22/24 T

Uralsib reported for 6 months of 2024 by RAS

7/22/24 USBN

MTS-Bank reported for 6 months of 2024 by RAS

7/22/24 MBNK

State-owned shareholding of TGC-2 is transferred to GEKH management

7/22/24 TGKB

T-Bank reported for for 6 months of 2024 by RAS

7/22/24 T

Sovcombank reported for 6 months of 2024 by RAS

7/22/24 SVCB